Equibles does not estimate personal net worth.
Get an email with a short summary when Structure Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get GPCR alertsJun Yoon is recorded as CFO at Structure Therapeutics Inc. (GPCR). The newest filing on record that lists Jun Yoon as CFO at Structure Therapeutics Inc. (GPCR) is dated April 23, 2026. The proxy statement of Structure Therapeutics Inc. reports total compensation of $4,467,595 for Jun Yoon in fiscal 2025, including a base salary of $530,530. Disclosed compensation is on record for 3 fiscal years. Jun Yoon has spoken on 1 investor event across 1 company, most recently for Structure Therapeutics Inc. on June 9, 2026. Structure Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Structure Therapeutics Inc. includes Raymond Stevens (CEO and Board Member), Matthew Lang (COO and General Counsel), Yingli Ma (CTO) and 2 others.
“Yeah, so, you know, this is a rapidly evolving space, as you can imagine, and price has been coming down.”
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Structure Therapeutics Inc. (GPCR) | Chief Financial Officer | $530,530 | $4,467,595 |
| 2024 | Structure Therapeutics Inc. (GPCR) | Chief Financial Officer | $482,300 | $2,813,362 |
| 2023 | Structure Therapeutics Inc. (GPCR) | Chief Financial Officer | $441,262 | $3,674,770 |
